Apyx Medical Corp. (NASDAQ: APYX) reported Q3 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $9.11 million versus the consensus estimate of $12.26 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.